Announcements Trials
Browse Landscape

Phase

Phase 1 14Phase 2 10Phase 1/2 10Phase 3 3Phase NA 2Phase 2/3 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 1059Neoplasms 885Prostatic Neoplasms 510Lung Neoplasms 426Colorectal Neoplasms 358Motor Activity 226Uterine Cervical Neoplasms 194Head and Neck Neoplasms 194Carcinoma, Non-Small-Cell Lung 182Brain Neoplasms 174Pancreatic Neoplasms 162Ovarian Neoplasms 143Colonic Neoplasms 140Carcinoma, Hepatocellular 136Anxiety Disorders 125Rectal Neoplasms 119Hematologic Neoplasms 115Multiple Myeloma 109Stomach Neoplasms 105Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Melanoma 93Depression 93Pain 89Urinary Bladder Neoplasms 88Endometrial Neoplasms 87Glioblastoma 86Disease 85Lymphoma 84Sarcoma 78

Interventions

Valganciclovir 1Valacyclovir 1Radiotherapy, Intensity-Modulated 1Phantoms, Imaging 1Magnetic Resonance Spectroscopy 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Epstein-Barr Virus Infections × 1 year × Clear all
NCT06682442 2026-05-01

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

University of California, San Francisco

Phase NA Recruiting
66 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT07294547 2025-12-19

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study

National Taiwan University Hospital

Phase NA Recruiting
80 enrolled

Cytomegalovirus Infections, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡